To study hyperphosphorylation mechanisms of Tau we have developed and validated a new cell-based AD model by differentiating SH-SY5Y into mature neurons featuring morphological and p-Tau characteristics with administration of GA to trigger the Tau aberrant phosphorylation [26,33]. This evidence concerns the gene MAPT and Alzheimer disease.